Clinical Trial Update: Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 [NA]

View source ↗

Summary

A Cleveland Clinic-sponsored trial is evaluating HMB-enriched amino acid supplementation in patients with alcoholic liver disease and COVID-19 and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Disease
• COVID-19 Pneumonia

Drugs mentioned

• HMB-enriched amino acid supplementation (beta-hydroxy beta-methylbutyrate (HMB))

Snippet

Sponsor: The Cleveland Clinic | Conditions: Alcoholic Liver Disease, COVID 19 Pneumonia | NA | Status: RECRUITING